LX‐2 cells were seeded in 96‐well plates with DMEM which included 1% FBS for 24 hours. Then, the cells were exposed to different concentrations of PDGF‐BB (0‐1000 ng/mL) or bFGF (0‐60 ng/mL) for 24 hours or lenvatinib (0‐200 nmol/L) for 24, 48 or 72 hours. Moreover, for other set of experiments, the cells were pre‐treated with PDGF‐BB (50 ng/mL) or bFGF (10 ng/mL) for 2 hours and then were treated with lenvatinib (0‐400 nmol/L) for 24 hours. The BrdU Cell Proliferation ELISA (Cosmo Bio, Tokyo, Japan) was used to evaluate cell proliferation according to the manufacturer's protocol.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.